Related Experiment Videos
Apoptosis in B-chronic lymphocytic leukaemia
L M Osorio1, M Aguilar-Santelises
1Hematology Department, Karolinska Hospital, Stockholm, Sweden. lydoso@ki.se
Medical Oncology (Northwood, London, England)
|February 10, 1999
Summary
B-chronic lymphocytic leukaemia (B-CLL) involves abnormal B-cell accumulation due to extended cell survival and reduced cell death. Receptor signals and the Fas/FasL system influence B-CLL progression by modulating apoptosis and immune response.
Area of Science:
- Hematology
- Immunology
- Molecular Biology
Background:
- B-chronic lymphocytic leukaemia (B-CLL) is a clonal expansion of malignant B lymphocytes.
- Disease progression is linked to factors influencing B-cell survival, proliferation, and apoptosis.
Purpose of the Study:
- To review the role of receptor-mediated signals in B-CLL cell survival.
- To examine gene modulation concerning apoptosis in B-CLL.
- To discuss the Fas/FasL system's impact on leukaemic cell accumulation and disease progression.
Main Methods:
- Literature review of studies on B-CLL cell signaling pathways.
- Analysis of data on gene expression and apoptosis regulation in B-CLL.
- Examination of the Fas/FasL system's function in B-CLL.
Main Results:
- Surface receptors like IgM, CD6, and CD40 significantly impact B-CLL cell survival.
- Gene modulation plays a crucial role in regulating apoptosis in B-CLL cells.
- The Fas/FasL system may contribute to disease progression by inhibiting apoptosis and evading immune surveillance.
Conclusions:
- Receptor signaling pathways are critical determinants of B-CLL cell lifespan.
- Dysregulation of apoptosis, influenced by gene modulation and the Fas/FasL system, drives B-CLL progression.
- Targeting these pathways offers potential therapeutic strategies for B-CLL.